Atom Fine Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 39.50%
- Profit Growth -60.69%
- Ebitda 226.01%
- Net Worth -240.93%
- Total Assets -8.24%
About Atom Fine Chemicals
Atom Fine Chemicals Private Limited (AFCPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 June 2020 (Four years and seven months 23 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sreenivasulu Guntha, Venu Veldi, and Ravi Annambhotla serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290TG2020PTC140763
-
Company No.
140763
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jun 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Atom Fine Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasulu Guntha
|
Director | 11-Jun-2020 | Current |
|
Venu Veldi
|
Director | 07-Dec-2020 | Current |
|
Ravi Annambhotla
|
Director | 11-Jun-2020 | Current |
Financial Performance of Atom Fine Chemicals.
Atom Fine Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.5% increase. The company also saw a substantial fall in profitability, with a 60.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 240.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atom Fine Chemicals?
In 2023, Atom Fine Chemicals had a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aap Pharma Technologies India Private LimitedSreenivasulu Guntha is a mutual person
-
Synventia Pharma Private LimitedVenu Veldi is a mutual person
-
Chemxzen Labs Private Limited
Venu Veldi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atom Fine Chemicals?
Atom Fine Chemicals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atom Fine Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atom Fine Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
